medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 16, 2023
ABSTRACT
Introduction
While
older
adults
generally
mount
weaker
antibody
responses
to
a
primary
COVID-19
vaccine
series,
T-cell
remain
less
well
characterized
in
this
population.
We
compared
SARS-CoV-2
spike-specific
after
two-
and
three-dose
mRNA
vaccination
subsequent
breakthrough
infection
younger
adults.
Methods
quantified
CD4+
CD8+
T-cells
reactive
overlapping
peptides
spanning
the
ancestral
spike
protein
40
(median
age
79)
50
health
care
workers
39),
all
naive,
using
an
activation
induced
marker
assay.
were
further
assessed
24
participants,
including
8
adults,
who
subsequently
experienced
their
first
infection.
Results
A
third
dose
significantly
boosted
frequencies
above
two-dose
levels
did
not
differ
between
either
dose.
Multivariable
analyses
adjusting
for
sociodemographic,
vaccine-related
variables
confirmed
that
was
associated
with
impaired
cellular
responses.
Instead,
strongest
predictors
of
post-third-dose
corresponding
post-second-dose
frequencies.
Breakthrough
increased
both
T
cell
frequencies,
comparable
Exploratory
revealed
association
HLA-A*02:03
higher
post-vaccination
which
may
be
attributable
numerous
strong-binding
HLA-A*02:03-specific
epitopes
spike.
Conclusion
Older
robust
vaccination,
are
following
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 13, 2024
Abstract
The
rapid
global
distribution
of
COVID-19
vaccines,
with
over
a
billion
doses
administered,
has
been
unprecedented.
However,
in
comparison
to
most
identified
clinical
determinants,
the
implications
individual
genetic
factors
on
antibody
responses
post-COVID-19
vaccination
for
breakthrough
outcomes
remain
elusive.
Here,
we
conducted
population-based
study
including
357,806
vaccinated
participants
high-resolution
HLA
genotyping
data,
and
subset
175,000
serology
test
results.
We
confirmed
prior
findings
that
single
nucleotide
polymorphisms
associated
response
are
predominantly
located
Major
Histocompatibility
Complex
region,
expansive
HLA-DQB1*06
gene
alleles
linked
improved
responses.
our
results
did
not
support
claim
this
mutation
alone
can
significantly
reduce
risk
general
population.
In
addition,
discovered
validated
six
(A*03:01,
C*16:01,
DQA1*01:02,
DQA1*01:01,
DRB3*01:01,
DPB1*10:01)
independently
influence
demonstrated
combined
effect
across
genes
outcomes.
Lastly,
estimated
vaccine-induced
positivity
provides
approximately
20%
protection
against
infection
50%
severity.
These
have
immediate
functional
studies
molecules
inform
future
personalised
strategies.
HLA,
Journal Year:
2023,
Volume and Issue:
102(6), P. 707 - 719
Published: July 19, 2023
The
remarkable
variability
of
response
to
vaccines
against
SARS-CoV-2
is
apparent.
present
study
aims
estimate
the
extent
which
host
genetic
background
contributes
this
in
terms
immune
and
side
effects
following
administration
BNT162b2
vaccine.
We
carried
out
a
genome
wide
association
(GWAS)
by
genotyping
873
Italian
healthcare
workers
who
underwent
anti-SARS-CoV-2
vaccination
with
vaccine
for
whom
information
about
spike
antibodies
titers
were
available.
GWAS
revealed
significant
between
HLA
locus
Spike
level
at
2
months
first
dose
(SNP:
rs1737060;
p
=
9.80
×
10-11
).
In
particular,
we
observed
positive
antibody
levels
presence
HLA-A*03:01
allele.
same
allele
was
found
associated
2-2.4-fold
increased
risk
experiencing
specific
such
as
fever,
chills
myalgia
1.5-1.8-fold
joint
pain,
nausea,
fatigue,
headache
asthenia,
independently
age
sex.
This
confirms
that
heterogeneity
its
are
least
partially
influenced
variants.
information,
integrated
individual
biological
lifestyle-related
correlates,
could
be
use
definition
algorithms
aimed
identification
subjects
additional
doses
would
particularly
beneficial
maintain
immunity
virus.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 24, 2025
Abstract
We
performed
a
retrospective
immunological
analysis
of
the
antibody
response
in
serum
and
nasopharyngeal
swabs
(NPS)
obtained
from
46
individuals
infected
with
ancestral
SARS-CoV-2
Wuhan-Hu-1
strain
during
first
COVID-19
wave
Cagliari
(Sardinia,
Italy),
4-month
follow-up
after
hospital
admission.
implemented
comprehensive
mucosal
samples
using
assays
established
our
laboratories.
In
NPS
we
evaluated
viral
load
by
real
time
PCR,
presence
kinetics
anti-Spike
IgG
IgA
ELISA
as
well
their
anti-Wuhan
neutralization
activity,
showing
induction
persistence
anti-viral
immunity
at
level.
Neutralizing
antibodies
were
measured
safe
pseudovirus-based
assay
validated
comparison
standard
test
live
SARS-CoV-2.
cross-neutralizing
against
all
major
early
variants
concerns
(VoC)
sera.
Of
note,
detected
remarkable
reduction
neutralizing
activity
BA.1
compared
to
BA.2
BA.5
Omicron
subvariants,
which
was
confirmed
sera
an
analogous
cohort
patients
San
Raffaele
Milan,
geographically
distant
region
Italy,
virus
same
period
time.
HLA
genes
exhibit
a
high
degree
of
polymorphism,
contributing
to
genetic
variability
known
influence
immune
responses
infection.
Here
we
investigate
associations
between
polymorphism
and
serological
T-lymphocyte
the
BNT162b2
ChAdOx1
SARS-CoV-2
vaccines
within
population
receiving
maintenance
haemodialysis
(HD)
for
End-Stage
Renal
Disease
(ESRD).
Our
primary
objective
was
identify
alleles
associated
with
diminished
T-cellular
responsiveness
vaccination.
As
secondary
objective,
type
COVID-19
disease
outcomes
were
investigated
using
an
independent
ESRD
cohort
(n
=
327).
This
aimed
determine
if
poor
vaccine
response
also
linked
unfavourable
infection
outcomes.
In
main
study,
serum
from
225
infection-naïve
patients
HLA-typed
high-resolution
Next
Generation
Sequencing,
titres
analysed
presence
spike
glycoprotein-specific
antibodies
after
two
doses
A
subset
33)
tested
response.
Overall,
89%
200)
seroconverted,
but
only
18%
6)
cellular
subgroup
had
positive
The
class
II
DPB1*104:01,
DRB1*04:03
DRB1*14:04
I
B*08:01
B*18:01
found
significantly
correlate
seronegativity,
DQB1*06:01
correlated
responsiveness.
We
unable
analyse
effect
on
outcome
due
sample
size
limitations.
results
suggest
pathways
further
research
begin
elucidate
relationship
in
vulnerable
population.
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(7), P. 1686 - 1686
Published: June 28, 2023
After
the
start
of
worldwide
COVID-19
vaccination
campaign,
there
were
increased
reports
autoimmune
diseases
occurring
de
novo
after
vaccination.
This
in
silico
analysis
aimed
to
investigate
presence
protein
epitopes
encoded
by
BNT-162b2
mRNA
vaccine,
one
most
widely
administered
vaccines,
which
could
induce
autoimmunity
predisposed
individuals.The
FASTA
sequence
vaccine
served
as
key
input
Immune
Epitope
Database
and
Analysis
Resource.
Linear
peptides
with
90%
BLAST
homology
selected,
T-cell,
B-cell,
MHC-ligand
assays
without
MHC
restriction
searched
analyzed.
HLA
disease
associations
screened
on
HLA-SPREAD
platform
selecting
only
positive
markers.By
7
May
2023,
a
total
5693
corresponding
21
viral
but
also
human
proteins
found.
The
latter
included
CHL1,
ENTPD1,
MEAF6,
SLC35G2,
ZFHX2.
Importantly,
some
autoepitopes
may
be
presented
alleles
positively
associated
various
immunological
diseases.The
product
contains
immunogenic
that
trigger
phenomena
individuals
through
molecular
mimicry
mechanism.
Genotyping
for
help
identify
at
risk.
However,
further
wet-lab
studies
are
needed
confirm
this
hypothesis.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Aug. 16, 2023
The
bivalent
mRNA
vaccine
is
recommended
to
address
coronavirus
disease
variants,
with
additional
doses
suggested
for
high-risk
groups.
However,
the
effectiveness,
optimal
frequency,
and
number
of
remain
uncertain.
In
this
study,
we
examined
long-term
cellular
humoral
immune
responses
following
fifth
administration
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
in
patients
undergoing
hemodialysis.
To
our
knowledge,
first
study
monitor
data
on
immunity
dynamics
populations
after
five
vaccination,
including
vaccine.
Whereas
most
maintained
throughout
observation
period,
observed
reduced
reactivity
as
measured
by
ancestral-strain-stimulated
ELISpot
assay
a
subset
patients.
Half
individuals
(50%;
14/28)
three
months
dose,
despite
acquiring
immunity.
absence
relationship
between
positive
controls
T-Spot
suggests
that
these
alterations
were
specific
SARS-CoV-2.
multivariable
analysis,
participants
aged
≥70
years
showed
marginally
significant
lower
likelihood
having
reactive
results.
Notably,
among
14
who
received
heterologous
vaccines,
13
successfully
acquired
immunity,
supporting
effectiveness
strategy.
These
findings
provide
valuable
insights
future
vaccination
strategies
vulnerable
populations.
further
research
needed
evaluate
involvement
tolerance
exhaustion
through
repeated
optimize
immunization
strategies.
Abstract:
The
worldwide
spread
of
SARS-CoV-2
has
led
to
a
significant
economic
and
social
burden
on
global
scale.
Even
though
the
pandemic
concluded,
there
remains
apprehension
regarding
emergence
highly
transmissible
variants
capable
evading
immunity
induced
by
either
vaccination
or
prior
infection.
success
viral
penetration
is
specific
amino
acid
residues
Receptor
Binding
Motif
(RBM)
involved
in
attachment.
This
region
interacts
with
cellular
receptor
ACE2,
triggering
neutralizing
antibody
(nAb)
response.
In
this
study,
we
have
evaluated
immunogenicity
serum
from
individuals
who
received
single
dose
combination
different
vaccines
against
original
strain
mutated
linear
RBM.
Despite
modest
response
wild-type
RBM,
Omicron
exhibit
four
mutations
RBM
(S477N,
T478K,
E484A,
F486V)
that
result
even
lower
titers.
primary
immune
responses
observed
were
directed
towards
IgA
IgG.
While
nAbs
typically
target
RBD,
our
investigation
unveiled
reduced
seroreactivity
within
RBD's
crucial
subregion,
deficiency
may
implications
for
generation
protective
nAbs.
Evaluation
S1WT
S2WT
peptides
binding
using
microscale
thermophoresis
revealed
higher
affinity
(35
nM)
sequence
(GSTPCNGVEGFNCYF),
which
includes
FNCY
patch.
Our
findings
suggest
not
an
immunodominant
vaccinated
individuals.
Comprehending
intricate
dynamics
humoral
response,
its
interplay
evolution,
host
genetics
formulating
effective
strategies,
only
targeting
but
also
anticipating
potential
future
coronaviruses.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 342 - 342
Published: March 22, 2024
The
worldwide
spread
of
SARS-CoV-2
has
led
to
a
significant
economic
and
social
burden
on
global
scale.
Even
though
the
pandemic
concluded,
apprehension
remains
regarding
emergence
highly
transmissible
variants
capable
evading
immunity
induced
by
either
vaccination
or
prior
infection.
success
viral
penetration
is
due
specific
amino
acid
residues
receptor-binding
motif
(RBM)
involved
in
attachment.
This
region
interacts
with
cellular
receptor
ACE2,
triggering
neutralizing
antibody
(nAb)
response.
In
this
study,
we
evaluated
serum
immunogenicity
from
individuals
who
received
single
dose
combination
different
vaccines
against
original
strain
mutated
linear
RBM.
Despite
modest
response
wild-type
RBM,
Omicron
exhibit
four
mutations
RBM
(S477N,
T478K,
E484A,
F486V)
that
result
even
lower
titers.
primary
immune
responses
observed
were
directed
toward
IgA
IgG.
While
nAbs
typically
target
RBD,
our
investigation
unveiled
reduced
seroreactivity
within
RBD’s
crucial
subregion,
deficiency
may
have
implications
for
generation
protective
nAbs.
An
evaluation
S1WT
S2WT
peptides
binding
using
microscale
thermophoresis
revealed
higher
affinity
(35
nM)
sequence
(GSTPCNGVEGFNCYF),
which
includes
FNCY
patch.
Our
findings
suggest
not
an
immunodominant
vaccinated
individuals.
Comprehending
intricate
dynamics
humoral
response,
its
interplay
evolution,
host
genetics
formulating
effective
strategies,
targeting
only
but
also
anticipating
potential
future
coronaviruses.
Pathogens and Immunity,
Journal Year:
2023,
Volume and Issue:
8(1), P. 117 - 135
Published: Nov. 17, 2023
Introduction:
While
older
adults
generally
mount
weaker
antibody
responses
to
a
primary
COVID-19
vaccine
series,
T-cell
remain
less
well
characterized
in
this
population.
We
compared
SARS-CoV-2
spike-specific
after
2-
and
3-dose
mRNA
vaccination
subsequent
breakthrough
infection
younger
adults.
Methods:
quantified
CD4+
CD8+
T-cells
reactive
overlapping
peptides
spanning
the
ancestral
spike
protein
40
(median
age
79)
50
health
care
workers
39),
all
naive,
using
an
activation-induced
marker
assay.
were
further
assessed
24
participants,
including
8
adults,
who
subsequently
experienced
their
first
infection.
Results:
A
third
dose
significantly
boosted
frequencies
above
2-dose
levels
did
not
differ
between
either
dose.
Multivariable
analyses
adjusting
for
sociodemographic,
health,
vaccine-related
variables
confirmed
that
was
associated
with
impaired
cellular
responses.
Instead,
strongest
predictors
of
post-third-dose
corresponding
post-second-dose
frequencies.
Breakthrough
increased
both
frequencies,
comparable
Exploratory
revealed
association
HLA-A*02:03
higher
post-vaccination
which
may
be
attributable
numerous
strong-binding
HLA-A*02:03-specific
epitopes
protein.
Conclusion:
Older
robust
vaccination,
are
following